Bai Chunli Meets Deputy Director of American Ludwig Institute for Cancer Research

On April 27, Bai Chunli, Executive Vice President of CAS met with Andy Simpson, Deputy Director of the American Ludwig Institute for Cancer Research and his entourage of three. Dr. Simpson is in charge of development and research projects. Dr. Bai exchanged viewpoints with the visitors about the joint establishment of a CAS/ Ludwig Institute (Center) for Cancer Research in China, etc.

Nobel Prize Laureate Engaged as Honorary Professor

On May 9, Sidney Altman, laureate of the Nobel Prize in chemistry in 1989, was officially engaged as honorary professor of the institute of Biochemistry and Cell Biology of the Shanghai Institutes for Biological Sciences , CAS.

Professor Sidney Altman pleasantly accepted the letter of appointment granted by Dr. Li Lin and expressed that he greatly appreciated the remarkable work of the Institute of Biochemistry and Cell Biology in the field of life science, and that he was honored to be engaged as an honorary professor of the Institute. Sidney Altman lived his new work role as soon as he took the letter of appointment. After the ceremony, he had academic exchanges with experts from the State Key Laboratory of Molecular Biology , and gave a lecture entitled modes of inhibition of gene expression with RNA in the lecture hall of the Bio-Science Building.

Recombinant Staphylokinase for Injection (r-Sak) Comes into Mass Production

On May 11, the Ministry of Science and Technology held a news conference in Beijing, announcing that the recombinant Staphylokinase for Injection (r-Sak), a thrombus dissolving medicine for a cute myocardial infarction, developed by the Institute of Plant Physiology & Ecology, Shanghai Institutes for Biological Sciences and other institutions, has come into the stage of mass production.

The cardio-cerebrovascular disease is a kind of disease, which has caused the largest number of deaths in the world. The acute myocardial infarction caused by thrombus with its complications is the most dangerous cardio-cerebrovascular disease. In collaboration with cooperative enterprises, and coordinated more than 30 scientific research institutions, universities and hospitals, with the efforts of more than150 people related, the Institute developed the recombinant Staphylokinase for Injection (r-Sak), a thrombus dissolving medicine for a cute myocardial infarction, which is fast and safe in dissolving the thrombus, excellent in performance and low in price. The workshop for production has passed the national GMP authentication. It is the first international Staphylokinase medicine for dissolving thrombus registered and approved for production. The medicine enjoys its proprietary intellectual property right and has now come into the stage of mass production.

Primate Research Center Established in Kunming

On May 19, a grand ceremony for the establishment of the Kunming Primate Research Center of CAS was held in the Kunming Institute of Zoology, CAS. Chen Zhu, Vice President of CAS, and Tang Lilu, Assistant Governor of Yunnan Province, attended the ceremony.

At the establishment ceremony, Chen Zhu pointed out in his speech that the establishment of the Kunming Primate Research Center of CAS is one of the important measures of the pilot projects of the Knowledge Innovation Program in the new stage of creative leap-forward and sustainable development, and that it also specifically displays that CAS has further strengthened the research in population and health based on the needs and requirements of the country. He made clear requirements about the future development and target of the center: with common concern and support, through the innovation of systems and mechanism, the center should be built into a first-class international platform for research, resources, international cooperation, industrialization, and cooperation between CAS and local authorities, which will serve as one of the important bases for research in bio-medical experiments in China and even in the world.

Chen Zhu Attended Sino-Japanese Forum on Molecular Medicine

0n April 29, Chen Zhu, Vice President of CAS and Yutaka Kirino, Vice President of the Tokyo University signed an agreement on academic exchanges and cooperation between CAS and the Tokyo University.

On the evening of April 29, in the name of the President of the Graduate School of CAS, Bai Chunli, Executive Vice President of CAS, bestowed the Certificate of Honorary Professorship on Hiroshi Komiyama, President of the Tokyo University.